BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fričová D, Korchak JA, Zubair AC. Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease. NPJ Regen Med 2020;5:20. [PMID: 33298940 DOI: 10.1038/s41536-020-00106-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther 2022;7:272. [PMID: 35933430 DOI: 10.1038/s41392-022-01134-4] [Reference Citation Analysis]
2 Chopade P, Chopade N, Zhao Z, Mitragotri S, Liao R, Chandran Suja V. Alzheimer's and Parkinson's disease therapies in the clinic. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10367] [Reference Citation Analysis]
3 Assali M, Kittana N, Alhaj-Qasem S, Hajjyahya M, Abu-Rass H, Alshaer W, Al-Buqain R. Noncovalent functionalization of carbon nanotubes as a scaffold for tissue engineering. Sci Rep 2022;12:12062. [PMID: 35835926 DOI: 10.1038/s41598-022-16247-7] [Reference Citation Analysis]
4 Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Moussa Agha D, Fahmi H, Lewalle P, Fayyad-Kazan M, Merimi M. Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Front Cell Dev Biol 2021;9:716853. [PMID: 35096805 DOI: 10.3389/fcell.2021.716853] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
5 Sun Z, Gu P, Xu H, Zhao W, Zhou Y, Zhou L, Zhang Z, Wang W, Han R, Chai X, An S. Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms. Front Cell Dev Biol 2022;9:808905. [DOI: 10.3389/fcell.2021.808905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Nelke A, García-lópez S, Martínez-serrano A, Pereira MP. Multifactoriality of Parkinson’s Disease as Explored Through Human Neural Stem Cells and Their Transplantation in Middle-Aged Parkinsonian Mice. Front Pharmacol 2022;12:773925. [DOI: 10.3389/fphar.2021.773925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gallo A, Cuscino N, Contino F, Bulati M, Pampalone M, Amico G, Zito G, Carcione C, Centi C, Bertani A, Conaldi PG, Miceli V. Changes in the Transcriptome Profiles of Human Amnion-Derived Mesenchymal Stromal/Stem Cells Induced by Three-Dimensional Culture: A Potential Priming Strategy to Improve Their Properties. Int J Mol Sci 2022;23:863. [PMID: 35055049 DOI: 10.3390/ijms23020863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Warrier S, Mohana Sundaram S, Varier L, Balasubramanian A. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19? Placenta 2021;117:161-8. [PMID: 34915433 DOI: 10.1016/j.placenta.2021.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lee OJ, Koch TG. Steps Toward Standardized In Vitro Assessment of Immunomodulatory Equine Mesenchymal Stromal Cells Before Clinical Application. Stem Cells Dev 2021. [PMID: 34779250 DOI: 10.1089/scd.2021.0189] [Reference Citation Analysis]
10 Kim IK, Park JH, Kim B, Hwang KC, Song BW. Recent advances in stem cell therapy for neurodegenerative disease: Three dimensional tracing and its emerging use. World J Stem Cells 2021; 13(9): 1215-1230 [PMID: 34630859 DOI: 10.4252/wjsc.v13.i9.1215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rodriguez-Pallares J, Garcia-Garrote M, Parga JA, Labandeira-Garcia JL. Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model. J Cell Mol Med 2021;25:9884-9. [PMID: 34535974 DOI: 10.1111/jcmm.16900] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Mohana Devi S, Abishek Kumar B, Mahalaxmi I, Balachandar V. Leber's hereditary optic neuropathy: Current approaches and future perspectives on Mesenchymal stem cell-mediated rescue. Mitochondrion 2021;60:201-18. [PMID: 34454075 DOI: 10.1016/j.mito.2021.08.013] [Reference Citation Analysis]
13 Cho E, Park J, Kim K, Kim MG, Cho SR. Reelin Alleviates Mesenchymal Stem Cell Senescence and Reduces Pathological α-Synuclein Expression in an In Vitro Model of Parkinson's Disease. Genes (Basel) 2021;12:1066. [PMID: 34356083 DOI: 10.3390/genes12071066] [Reference Citation Analysis]
14 Mukherjee S, Yadav G, Kumar R. Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine. World J Stem Cells 2021; 13(6): 521-541 [PMID: 34249226 DOI: 10.4252/wjsc.v13.i6.521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
15 Hug K. Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical Issues. J Parkinsons Dis 2021. [PMID: 34092655 DOI: 10.3233/JPD-212639] [Reference Citation Analysis]
16 Mata-Miranda MM, Sanchez-Brito M, Vazquez-Zapien GJ. Different kinds of stem cells in the development of SARS-CoV-2 treatments. World J Stem Cells 2021; 13(5): 439-451 [PMID: 34136074 DOI: 10.4252/wjsc.v13.i5.439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lin Y, Ren X, Chen Y, Chen D. Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment. Front Neurosci 2020;14:617377. [PMID: 33551729 DOI: 10.3389/fnins.2020.617377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Miceli V, Bulati M, Iannolo G, Zito G, Gallo A, Conaldi PG. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine. Int J Mol Sci 2021;22:E763. [PMID: 33466583 DOI: 10.3390/ijms22020763] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 33.0] [Reference Citation Analysis]